India Reports Isolated Mpox Case, Confirms Older Strain
India identifies a single mpox case from the older West African strain, not the new variant causing global concern. Government issues nationwide alert for vigilance against potential outbreaks.
India has reported an isolated case of mpox in a traveler, confirming it to be from the older West African clade 2 strain. This development comes amidst global concerns over a new, rapidly spreading mpox variant.
Indian health authorities stated, "Laboratory testing has confirmed the presence of mpox virus of the West African clade 2 in the patient. This case is an isolated one, similar to the 30 earlier cases reported in India from July 2022 onwards."
It's important to note that India has not yet recorded any instances of the new mpox strain. However, the government has issued a nationwide advisory, urging all states to remain vigilant and prepared for potential cases.
This precautionary measure follows the World Health Organization's (WHO) decision to declare the new mpox outbreak a global health emergency for the second time in approximately two years. The declaration underscores the seriousness of the situation and the need for coordinated international response.
Mpox, formerly known as monkeypox until the WHO changed its name in November 2022, typically manifests with flu-like symptoms and pus-filled lesions. While usually mild, it can be fatal in some cases. High-risk groups include children, pregnant women, and individuals with compromised immune systems, such as those living with HIV.
Some interesting facts about mpox:
- The virus was first discovered in 1958 in a colony of research monkeys.
- The first human case was recorded in 1970 in the Democratic Republic of Congo.
- Mpox is endemic in several Central and West African countries.
- The 2022 outbreak marked the first time the virus spread widely outside endemic regions.
- The incubation period typically ranges from 6 to 13 days but can extend up to 21 days.
- Symptoms usually last 2 to 4 weeks.
- Two vaccines are available for mpox prevention.
- Antiviral drugs developed for smallpox can treat severe mpox cases.
- The fatality rate varies between 1% and 10%, depending on the strain.
- While less contagious than COVID-19 or influenza, mpox can spread through close contact and, less commonly, respiratory droplets.
As the global health community continues to monitor the situation, it's crucial for individuals to stay informed and follow guidelines provided by health authorities to prevent the spread of mpox.
